Programme): an international survey. Lancet 2002, 360:1631?639. Rutten FH, Grobbee DE, Hoes AW: Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5:337?44. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, et al: Prognostic value of 6-minute walk corridor test in patients
The European society of cardiology: developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803?69. Rose GA, Blackburn H: Cardiovascular survey methods. Geneva: World Health Organisation; 1982. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification: a report from the American society
Programme): an international survey. Lancet 2002, 360:1631?639. Rutten FH, Grobbee DE, Hoes AW: Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5:337?44. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, et al: Prognostic value of 6-minute walk corridor test in patients
Fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J 2007, 28:2539?550. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613?18.25. Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler RD, et al: Examination of the six minute
Evaluated. Laboratorial tests included total cholesterol, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, hemoglobin A1c, serum creatinine, Creactive protein and microalbuminuria. Body mass index, GFR (MDRD formula) and Framingham risk score [17] were calculated. Hypertension and dyslipidemia were defined by a self-reported history or use of specific thera
Evaluated. Laboratorial tests included total cholesterol, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, hemoglobin A1c, serum creatinine, Creactive protein and microalbuminuria. Body mass index, GFR (MDRD formula) and Framingham risk score [17] were calculated. Hypertension and dyslipidemia were defined by a self-reported history or use of specific thera
Level (p) are shown. Legend: GFR - Glomerular Filtration Rate. Presented parameters are related to initial assessment and data obtained by Computed tomography.were initiated on statins, which was a significant change (p = 0.041). Treatment with an antiplatelet agent, a statin or percutaneous revascularisation was started in 17.6 of patients following CT, which was also a significant change (p = 0
Level (p) are shown. Legend: GFR - Glomerular Filtration Rate. Presented parameters are related to initial assessment and data obtained by Computed tomography.were initiated on statins, which was a significant change (p = 0.041). Treatment with an antiplatelet agent, a statin or percutaneous revascularisation was started in 17.6 of patients following CT, which was also a significant change (p = 0